Company profile
ScubaTx
ScubaTx is a breakthrough organ preservation device organ transplant. The ScubaTx device will leverage world-leading expertise in software design to commercialise a proven but unexploited organ preservation technique, Persufflation. ScubaTx will offer healthcare providers significant net savings, and so help clinicians around the world to increase the pool of life-giving organs for transplant.
Financial period: 1 Mar 2024 to 28 Feb 2025
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
SH01 | Transaction MzQzNTQzNjg3M2FkaXF6a2N4
Published 12 Sep 2024 12:13
Company registered at Companies House
ScubaTx develops an organ preservation system.
ScubaTx develops an organ preservation system based on cold saline storage, and develops a mobile app providing feedback and updates on organ status for users.
1.8M£ ongoing fund raise, development of new medical device for organ preservation
1 Sep 2025 to 31 Mar 2026
The ALBUM project, led by ARC Aerosystems, advances uncrewed aerial systems (UAS) to revolutionize logistics and medical transport in remote areas, such as the Scottish Highlands and Islands. By enhancing the C600 UAV---a high-capacity, long-range, hybrid vertical take-off and landing aircraft---ALBUM aims to achieve Beyond Visual Line of Sight (BVLOS) an...
1 Jun 2025 to 30 Nov 2026
A lung transplant is the only treatment for many end-stage patients suffering from lung failure. Lung failure is when the lungs can't get enough oxygen. It can be caused by an injury or by several diseases, for example; * chronic obstructive pulmonary disease, * pulmonary arterial hypertension, * cystic fibrosis, * idiopathic pulmonary fibrosis. Most tran...
1 Jul 2024 to 31 Dec 2025
**Problem** Organ transplantation is the only affordable solution for many suffering end-stage organ-failure. Transplantation enables patients to live longer more fulfilled lives and reduces costs to the NHS over £300M/year. Organ demand far outstrips supply. Recent changes in law have tried to increase donor numbers by presuming consent, but organising o...
1 Apr 2023 to 30 Sep 2024
**Problem** Organ transplantation is the only available treatment for many patients suffering end-stage organ-failure. Transplantation enables longer life-expectancy, improved quality-of-life and reduced costs, versus standard-of-care. NHS transplant programme saves \>£300M/year. Transplant teams are overworked, and long unsociable hours limits staff recr...
1 Dec 2021 to 30 Nov 2022
